Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations?
Bradbury, Alice, Hall, Sally, Curtin, Nicola, Drew, Yvette
Published in Pharmacology & therapeutics (Oxford) (01.03.2020)
Published in Pharmacology & therapeutics (Oxford) (01.03.2020)
Get full text
Journal Article
DNA damage checkpoint kinases in cancer
Smith, Hannah L., Southgate, Harriet, Tweddle, Deborah A., Curtin, Nicola J.
Published in Expert reviews in molecular medicine (01.01.2020)
Published in Expert reviews in molecular medicine (01.01.2020)
Get full text
Journal Article
Mentoring the Next Generation of Faculty: Supporting Academic Career Aspirations Among Doctoral Students
Curtin, Nicola, Malley, Janet, Stewart, Abigail J.
Published in Research in higher education (01.09.2016)
Published in Research in higher education (01.09.2016)
Get full text
Journal Article
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers
de Bono, Johann, Ramanathan, Ramesh K, Mina, Lida, Chugh, Rashmi, Glaspy, John, Rafii, Saeed, Kaye, Stan, Sachdev, Jasgit, Heymach, John, Smith, David C, Henshaw, Joshua W, Herriott, Ashleigh, Patterson, Miranda, Curtin, Nicola J, Byers, Lauren Averett, Wainberg, Zev A
Published in Cancer discovery (01.06.2017)
Published in Cancer discovery (01.06.2017)
Get full text
Journal Article
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
Berger, Nathan A, Besson, Valerie C, Boulares, A Hamid, Bürkle, Alexander, Chiarugi, Alberto, Clark, Robert S, Curtin, Nicola J, Cuzzocrea, Salvatore, Dawson, Ted M, Dawson, Valina L, Haskó, György, Liaudet, Lucas, Moroni, Flavio, Pacher, Pál, Radermacher, Peter, Salzman, Andrew L, Snyder, Solomon H, Soriano, Francisco Garcia, Strosznajder, Robert P, Sümegi, Balázs, Swanson, Raymond A, Szabo, Csaba
Published in British journal of pharmacology (01.01.2018)
Published in British journal of pharmacology (01.01.2018)
Get full text
Journal Article
PARP inhibitor development for systemic cancer targeting
Zaremba, Tomasz, Curtin, Nicola Jane
Published in Anti-cancer agents in medicinal chemistry (01.09.2007)
Published in Anti-cancer agents in medicinal chemistry (01.09.2007)
Get more information
Journal Article
Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy
Curtin, Nicola J., Drew, Yvette, Sharma-Saha, Sweta
Published in Nature reviews. Clinical oncology (01.12.2019)
Published in Nature reviews. Clinical oncology (01.12.2019)
Get full text
Journal Article
DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival
Cornell, Liam, Munck, Joanne M, Alsinet, Clara, Villanueva, Augusto, Ogle, Laura, Willoughby, Catherine E, Televantou, Despina, Thomas, Huw D, Jackson, Jennifer, Burt, Alastair D, Newell, David, Rose, John, Manas, Derek M, Shapiro, Geoffrey I, Curtin, Nicola J, Reeves, Helen L
Published in Clinical cancer research (15.02.2015)
Published in Clinical cancer research (15.02.2015)
Get full text
Journal Article
Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer
Batey, Michael A, Zhao, Yan, Kyle, Suzanne, Richardson, Caroline, Slade, Andrew, Martin, Niall M B, Lau, Alan, Newell, David R, Curtin, Nicola J
Published in Molecular cancer therapeutics (01.06.2013)
Published in Molecular cancer therapeutics (01.06.2013)
Get full text
Journal Article
Targeting the S and G2 checkpoint to treat cancer
Chen, Tao, Stephens, Peter A., Middleton, Fiona K., Curtin, Nicola J.
Published in Drug discovery today (01.03.2012)
Published in Drug discovery today (01.03.2012)
Get full text
Journal Article